Get the full picture
Sign in to uncover key details.
Hopec Pharma
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Hateena St, Givat Shmuel, 5440101, Isr...Website
www.hopec-pharma.comRevenue
$16.9 MillionIndustry
About Hopec Pharma
Hopec Pharma is revolutionizing the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) with its flagship product, UPEC-FimON, an innovative immunotherapy designed to target and eliminate bladder cancer cells using a genetically modified E. coli bacterium. The company is committed to enhancing patient outcomes and transforming cancer care through advanced therapies and strategic global partnerships. Hopec Pharma is focused on making these innovative treatments accessible worldwide, accelerating yet another step in cancer therapy. With ongoing clinical trials and a strong research foundation, they continue to push the boundaries of cancer treatment.Explore more
Hopec Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Hopec Pharma Tech Stack
A closer look at the technologies used by Hopec Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hopec Pharma
Sign Up For FreeTo access detailed company insights
Hopec Pharma is revolutionizing the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) with its flagship product, UPEC-FimON, an innovative immunotherapy designed to target and eliminate bladder cancer cells using a genetically modified E. coli bacterium. The company is committed to enhancing patient outcomes and transforming cancer care throu... Read More
